Clinical Trials Browser

Not yet recruiting × tislelizumab × Lymphoid × Clear all

NCT07031700 2025-06-22

A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FL

Phase 2 Not yet recruiting

Lymphoma, Follicular

NCT06761911 2025-01-07

BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma

Phase 4 Not yet recruiting

Hodgkin Disease, Recurrence

NCT05627115 2023-11-29

RATiFY

Phase 2 Not yet recruiting

Hodgkin Disease